Literature DB >> 15004555

Distinct regions in the CD28 cytoplasmic domain are required for T helper type 2 differentiation.

Pietro G Andres1, Kimberly C Howland, Ajay Nirula, Lawrence P Kane, Luke Barron, Douglas Dresnek, Ali Sadra, John Imboden, Arthur Weiss, Abul K Abbas.   

Abstract

CD28 costimulation is essential for CD4(+) T cell proliferation, survival, interleukin 2 (IL-2) production and T helper type 2 development. To define the nature of the signals that may drive different T cell responses, we have done a structure-function analysis of the CD28 cytoplasmic tail in primary T cells. CD28-mediated T cell proliferation and IL-2 production did not require a particular cytoplasmic domain. In contrast, IL-4 production was driven by the cooperative activity of specific motifs within the CD28 cytoplasmic tail. Using a gene-complementation approach, we provide evidence that one component of this T helper type 2 differentiation signal was mediated by 3-phosphoinositide-dependent protein kinase 1. Thus, different mechanisms underlie the induction of distinct T cell functional responses by CD28.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004555     DOI: 10.1038/ni1044

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  20 in total

Review 1.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

Review 2.  Immunogenomics and systems biology of vaccines.

Authors:  Luigi Buonaguro; Bali Pulendran
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

3.  In the absence of its cytosolic domain, the CD28 molecule still contributes to T cell activation.

Authors:  Stéphanie O Morin; Valentin Giroux; Cédric Favre; Yassina Bechah; Nathalie Auphan-Anezin; Romain Roncagalli; Jean-Louis Mège; Daniel Olive; Marie Malissen; Jacques A Nunès
Journal:  Cell Mol Life Sci       Date:  2015-03-01       Impact factor: 9.261

4.  Induction of autoimmune disease in CTLA-4-/- mice depends on a specific CD28 motif that is required for in vivo costimulation.

Authors:  Xuguang Tai; Francois Van Laethem; Arlene H Sharpe; Alfred Singer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-16       Impact factor: 11.205

5.  Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways.

Authors:  Keunwook Lee; Prathyusha Gudapati; Srdjan Dragovic; Charles Spencer; Sebastian Joyce; Nigel Killeen; Mark A Magnuson; Mark Boothby
Journal:  Immunity       Date:  2010-06-25       Impact factor: 31.745

Review 6.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

7.  Targeted knock-in mice expressing mutations of CD28 reveal an essential pathway for costimulation.

Authors:  Lindzy F Dodson; Jonathan S Boomer; Christine M Deppong; Dulari D Shah; Julia Sim; Traci L Bricker; John H Russell; Jonathan M Green
Journal:  Mol Cell Biol       Date:  2009-04-27       Impact factor: 4.272

8.  Role for the CD28 molecule in the control of Coxiella burnetii infection.

Authors:  Amélie Honstettre; Soraya Meghari; Jacques A Nunès; Hubert Lepidi; Didier Raoult; Daniel Olive; Jean-Louis Mege
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

9.  Spatiotemporal regulation of T cell costimulation by TCR-CD28 microclusters and protein kinase C theta translocation.

Authors:  Tadashi Yokosuka; Wakana Kobayashi; Kumiko Sakata-Sogawa; Masako Takamatsu; Akiko Hashimoto-Tane; Michael L Dustin; Makio Tokunaga; Takashi Saito
Journal:  Immunity       Date:  2008-10-09       Impact factor: 31.745

10.  Signals and sequences that control CD28 localization to the central region of the immunological synapse.

Authors:  Mariano Sanchez-Lockhart; Beth Graf; Jim Miller
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.